We are live on ! Find out more
Nisa Investment Advisors

Nisa Investment Advisors Portfolio holdings

AUM $32B
1-Year Est. Return 32.86%
This Fund
S&P 500
This Quarter Est. Return
+9.06%
1 Year Est. Return
+32.86%
3 Year Est. Return
+108.44%
5 Year Est. Return
+138.89%
10 Year Est. Return
+505.54%
AUM
$25.9B
AUM Growth
+$3.74B
Cap. Flow
+$2B
Cap. Flow %
7.73%
Top 10 Hldgs %
53.49%
Holding
3,114
New
74
Increased
1,171
Reduced
910
Closed
135

Sector Composition

Rank Sector Weight
1 Technology 22.27%
2 Financials 9.62%
3 Communication Services 7.08%
4 Consumer Discretionary 6.44%
5 Industrials 6.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HSTM icon
2526
HealthStream
HSTM
$829M
$3.25K ﹤0.01%
115
+56
+95% +$1.54K
EDIT icon
2527
Editas Medicine
EDIT
$453M
$3.23K ﹤0.01%
932
ST icon
2528
Sensata Technologies
ST
$6.73B
$3.21K ﹤0.01%
105
+10
+11% +$316
INSP icon
2529
Inspire Medical Systems
INSP
$1.71B
$3.19K ﹤0.01%
43
-2,325
-98% -$235K
ACI icon
2530
Albertsons Companies
ACI
$5.95B
$3.15K ﹤0.01%
180
-50
-22% -$980
NVST icon
2531
Envista
NVST
$4.58B
$3.12K ﹤0.01%
153
ABCL icon
2532
AbCellera Biologics
ABCL
$2.99B
$3.07K ﹤0.01%
610
PLOW icon
2533
Douglas Dynamics
PLOW
$979M
$3.06K ﹤0.01%
98
+10
+11% +$313
OVID icon
2534
Ovid Therapeutics
OVID
$482M
$3.06K ﹤0.01%
2,351
ASC icon
2535
Ardmore Shipping
ASC
$662M
$3.05K ﹤0.01%
257
AMPY icon
2536
Amplify Energy
AMPY
$187M
$3.05K ﹤0.01%
581
PBPB
2537
DELISTED
Potbelly
PBPB
$3.03K ﹤0.01%
178
GALT icon
2538
Galectin Therapeutics
GALT
$316M
$3.03K ﹤0.01%
716
REKR icon
2539
Rekor Systems
REKR
$93.4M
$3.02K ﹤0.01%
1,925
CAVA icon
2540
CAVA Group
CAVA
$7.08B
$3.02K ﹤0.01%
50
-484
-91% -$36.7K
TTGT icon
2541
TechTarget
TTGT
$271M
$3.01K ﹤0.01%
518
+139
+37% +$921
ESPR
2542
DELISTED
Esperion Therapeutics
ESPR
$2.98K ﹤0.01%
1,126
+185
+20% +$358
NNOX icon
2543
Nano X Imaging
NNOX
$77.3M
$2.96K ﹤0.01%
800
-238
-23% -$1.06K
TAK icon
2544
Takeda Pharmaceutical
TAK
$55.8B
$2.93K ﹤0.01%
200
RXT icon
2545
Rackspace Technology
RXT
$1.11B
$2.87K ﹤0.01%
2,033
+369
+22% +$494
ACH
2546
Accendra Health
ACH
$96.9M
$2.85K ﹤0.01%
593
-3
-0.5% -$19
MRAM icon
2547
Everspin Technologies
MRAM
$400M
$2.82K ﹤0.01%
303
PACS icon
2548
PACS Group
PACS
$7.12B
$2.8K ﹤0.01%
204
-127
-38% -$1.49K
ADV icon
2549
Advantage Solutions
ADV
$387M
$2.79K ﹤0.01%
73
+8
+12% +$333
MAMA icon
2550
Mama's Creations
MAMA
$828M
$2.79K ﹤0.01%
265

Similar funds

Nisa Investment Advisors's Q3 2025 Portfolio in Review

As of Q3 2025, Nisa Investment Advisors held 3,114 positions worth $25.9B, up 17% from $22.2B the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Nisa Investment Advisors deployed $2B of net new capital in Q3 2025, opening 74 new positions and adding to 1,171 existing holdings. Its largest new stake was AngloGold Ashanti: 70,201 shares worth $4.94M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 25% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was NVIDIA, an estimated $118M trimmed.

  • Nisa Investment Advisors's largest Q3 2025 buy was AngloGold Ashanti: 70,201 shares worth $4.94M.
  • Nisa Investment Advisors added most to iShares Core S&P 500 ETF in Q3 2025, an estimated $2.77B increase.
  • Nisa Investment Advisors's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $118M.
  • Nisa Investment Advisors fully exited iShares Core US Aggregate Bond ETF in Q3 2025, selling an estimated $396M.
  • Nisa Investment Advisors's ten largest holdings make up 53% of its $25.9B portfolio in Q3 2025.
  • Nisa Investment Advisors opened 74 new positions and closed 135 in Q3 2025.
  • Nisa Investment Advisors's portfolio value rose 17% quarter-over-quarter to $25.9B.

Based on Nisa Investment Advisors's 13F filing for Q3 2025, filed 23 Oct 2025.